Press Release BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 11 hours ago
Press Release BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress 12 hours ago